 |
|
|
| |
No neurocognitive benefit of immediate vs delayed tesamorelin in virally suppressed people with HIV
|
| |
| |
CROI 2024 March 3-6 Denver
Ronald J. Ellis1, Florin Vaida1, Keren Hu1, Michael Dube2, Brook Henry1, Felicia Chow3, Daniel Lee1, Fred Sattler4
1U.C. San Diego, San Diego, CA, U.S.A., 2AIDS Healthcare Foundation, Los Angeles, CA, U.S.A., 3U.C. San Francisco, San Francisco, CA, U.S.A., 4University of Southern California, Los Angeles, CA, U.S.A.
|
| |
|
|
|
|
|
